AC
Andy Chen Wolfe Research Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
|
VRNA
1
Verona Pharma
VRNA
$9.19B
| $106.24 | $170 |
60%
upside
| Outperform | 2 months ago |
|
2
BridgeBio Pharma
BBIO
$9.91B
| $51.83 | $49 |
5%
downside
| Outperform | 2 months ago |
|
3
Avidity Biosciences
RNA
$6.24B
| $48.47 | $55 |
13%
upside
| Outperform | 2 months ago |
|
4
MoonLake Immunotherapeutics
MLTX
$3.79B
| $59.72 | $61 |
2%
upside
| Outperform | 3 months ago |
|
5
Intellia Therapeutics
NTLA
$1.25B
| $11.62 | $21 |
81%
upside
| Outperform | 4 months ago |
|
|
ORKA
6
Oruka Therapeutics, Inc. Common Stock
ORKA
$561M
| $14.97 | $20 |
34%
upside
| Outperform | 7 months ago |
|
|
ZBIO
7
Zenas BioPharma, Inc. Common Stock
ZBIO
$715M
| $16.98 | $19 |
12%
upside
| Outperform | 7 months ago |
|
8
argenx
ARGX
$44.9B
| $733.66 | $697 |
5%
downside
| Outperform | 9 months ago |
|
9
Kymera Therapeutics
KYMR
$3.02B
| $42.20 | $65 |
54%
upside
| Outperform | 1 year ago |
|
10
Roivant Sciences
ROIV
$8.58B
| $12.57 | $17 |
35%
upside
| Outperform | 1 year ago |
|
11
Insmed
INSM
$30.1B
| $142.53 | $42 |
71%
downside
| Outperform | 1 year ago |
|